PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31812068-11	2020	Moreover, the inhibitory effect of SDG was partly dependent on the disruption of NF-kappaB activation.	secoisolariciresinol diglucoside	35-38	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	81-90	
31812068-12	2020	Our results indicated that SDG relieves colitis by inhibiting NLRP1 inflammasome, and partly dependent on the disruption of NF-kappaB activation.	secoisolariciresinol diglucoside	27-30	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	124-133	
30367332-6	2019	RESULTS: SDG supplementation in the mice significantly reduced tumor volume and expression of phospho-p65 and NF-kappaB target genes (P < 0.05).	secoisolariciresinol diglucoside	9-12	nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105	Mus musculus	110-119